Dezhan Healthcare Hits Day Low of CNY 3.43 Amid Price Pressure

Dezhan Healthcare Co., Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility today, with the stock dropping by 9.71% as of May 22, 2026. The stock reached an intraday low of CNY 3.43, reflecting ongoing challenges within the company. Over the past week, Dezhan Healthcare's performance has declined by 13.13%, contrasting sharply with the China Shanghai Composite, which saw a slight decrease of 0.54%. In the longer term, the company has struggled, with a year-to-date performance of -10.42% and a five-year decline of 35.82%. Key financial metrics indicate a concerning trend, with a low Return on Capital Employed (ROCE) of 1.63%, suggesting limited profitability relative to capital invested. Additionally, the company has reported negative net profit for the last seven consecutive quarters, with a staggering decline in operating profit over the past five years. Overall, Dezhan Healthcare's current market position reflects significant challenges, as evidenced by its underperformance compared to broader market indices.